igf 1 lr3 bone growth Recombinant human IGF-1 protein (Qk041) Application and benefits of IGF-1

Data Availability Statement Data sharing is not applicable to this article as no datasets were generated or analysed during the current study.

T cellspecific loss of GLS1, or pharmacologic inhibition of GLS1, results in decreased levels of glutamate, leading to increased ROS, which dampens Th17-dependent pathology in vivo (82)

Spatiotemporal loss of NF1 in Schwann cell lineage leads to different types of cutaneous neurofibroma susceptible to modification by the hippo pathway

Patients with vascular problems such as these may benefit more from intense pulsed light (IPL), a light-based therapy that eliminates small blood vessels and superficial discoloration